Suivre
Brigitte EVRARD
Brigitte EVRARD
Adresse e-mail validée de ulg.ac.be
Titre
Citée par
Citée par
Année
Microcrystalline cellulose, a direct compression binder in a quality by design environment—A review
G Thoorens, F Krier, B Leclercq, B Carlin, B Evrard
International journal of pharmaceutics 473 (1-2), 64-72, 2014
6932014
Systematic characterization of oil-in-water emulsions for formulation design
I Roland, G Piel, L Delattre, B Evrard
International journal of pharmaceutics 263 (1-2), 85-94, 2003
3472003
Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art
R Karim, C Palazzo, B Evrard, G Piel
Journal of controlled release 227, 23-37, 2016
2592016
Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications
S Jaspart, G Piel, L Delattre, B Evrard
Expert opinion on drug delivery 2 (1), 75-87, 2005
2152005
Design space approach in the optimization of the spray-drying process
P Lebrun, F Krier, J Mantanus, H Grohganz, M Yang, E Rozet, ...
European Journal of Pharmaceutics and Biopharmaceutics 80 (1), 226-234, 2012
2062012
A review of pharmaceutical extrusion: Critical process parameters and scaling-up
J Thiry, F Krier, B Evrard
International journal of pharmaceutics 479 (1), 227-240, 2015
1822015
Solid lipid microparticles as a sustained release system for pulmonary drug delivery
S Jaspart, P Bertholet, G Piel, JM Dogné, L Delattre, B Evrard
European journal of pharmaceutics and biopharmaceutics 65 (1), 47-56, 2007
1822007
Liposome surface charge influence on skin penetration behaviour
A Gillet, P Compère, F Lecomte, P Hubert, E Ducat, B Evrard, G Piel
International journal of pharmaceutics 411 (1-2), 223-231, 2011
1602011
Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound
T Van Hees, G Piel, B Evrard, X Otte, L Thunus, L Delattre
Pharmaceutical research 16, 1864-1870, 1999
1581999
Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives
ML Volvert, S Seyen, M Piette, B Evrard, M Gangolf, JC Plumier, ...
BMC pharmacology 8, 1-11, 2008
1562008
Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
DD Cataldo, MM Gueders, N Rocks, NE Sounni, B Evrard, P Bartsch, ...
Cellular and molecular biology (Noisy-le-Grand, France) 49 (6), 875-884, 2003
1562003
Skin penetration behaviour of liposomes as a function of their composition
A Gillet, F Lecomte, P Hubert, E Ducat, B Evrard, G Piel
European Journal of Pharmaceutics and Biopharmaceutics 79 (1), 43-53, 2011
1392011
Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now?
C Parulski, O Jennotte, A Lechanteur, B Evrard
Advanced drug delivery reviews 175, 113810, 2021
1242021
Supercritical fluid methods: An alternative to conventional methods to prepare liposomes
B William, P Noemie, E Brigitte, P Geraldine
Chemical Engineering Journal 383, 123106, 2020
1242020
Moisture content determination of pharmaceutical pellets by near infrared spectroscopy: method development and validation
J Mantanus, E Ziemons, P Lebrun, E Rozet, R Klinkenberg, B Streel, ...
Analytica chimica acta 642 (1-2), 186-192, 2009
1232009
Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics
G Piel, M Piette, V Barillaro, D Castagne, B Evrard, L Delattre
International journal of pharmaceutics 312 (1-2), 75-82, 2006
1182006
Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin
B Evrard, P Chiap, P DeTullio, F Ghalmi, G Piel, T Van Hees, J Crommen, ...
Journal of Controlled Release 85 (1-3), 45-50, 2002
1152002
Influence of composition and spray-drying process parameters on carrier-free DPI properties and behaviors in the lung: A review
A Lechanteur, B Evrard
Pharmaceutics 12 (1), 55, 2020
1102020
Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape
A Lechanteur, V Sanna, A Duchemin, B Evrard, D Mottet, G Piel
Nanomaterials 8 (5), 270, 2018
1092018
Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome
A Gillet, A Grammenos, P Compère, B Evrard, G Piel
International Journal of Pharmaceutics 380 (1-2), 174-180, 2009
1092009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20